Pharmaceutical combination
US6337324B1 · kind B1 · utility
14Cited by
8References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 1996 |
| Grant date | Jan 8, 2002 |
| Priority date | — |
| Expiry date | Mar 8, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.